Influence of dietary fat and carbohydrates proportions on plasma lipids, glucose control and low-grade inflammation in patients with type 2 diabetes—The TOSCA.IT Study
- 1.4k Downloads
The optimal macronutrient composition of the diet for the management of type 2 diabetes is debated, particularly with regard to the ideal proportion of fat and carbohydrates. The aim of the study was to explore the association of different proportions of fat and carbohydrates of the diet—within the ranges recommended by different guidelines—with metabolic risk factors.
We studied 1785 people with type 2 diabetes, aged 50–75, enrolled in the TOSCA.IT Study. Dietary habits were assessed using a validated food-frequency questionnaire (EPIC). Anthropometry, fasting lipids, HbA1c and C-reactive protein (CRP) were measured.
Increasing fat intake from <25 to ≥35 % is associated with a significant increase in LDL-cholesterol, triglycerides, HbA1c and CRP (p < 0.05). Increasing carbohydrates intake from <45 to ≥60 % is associated with significantly lower triglycerides, HbA1c and CRP (p < 0.05). A fiber intake ≥15 g/1000 kcal is associated with a better plasma lipids profile and lower HbA1c and CRP than lower fiber consumption. A consumption of added sugars of ≥10 % of the energy intake is associated with a more adverse plasma lipids profile and higher CRP than lower intake.
In people with type 2 diabetes, variations in the proportion of fat and carbohydrates of the diet, within the relatively narrow ranges recommended by different nutritional guidelines, significantly impact on the metabolic profile and markers of low-grade inflammation. The data support the potential for reducing the intake of fat and added sugars, preferring complex, slowly absorbable, carbohydrates.
KeywordsDiet Carbohydrates Fat Glucose control HDL-cholesterol Triglycerides Type 2 diabetes Nutritional guidelines
Compliance with Ethical Standards
Conflict of interest
The authors declare that they have no conflict of interest.
The study is supported by the Italian Medicines Agency (AIFA) within the Independent Drug Research Program contract n°. FARM6T9CET and by Diabete Ricerca, the no profit Research Foundation of the Italian Diabetes Society.
- 1.Bantle JP, Wylie-Rosett J, Albright AL, Apovian CM, Clark NG, Franz MJ et al (2008) American Diabetes Association. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care 31(Suppl. 1):S61–S78Google Scholar
- 6.Mann JI, De Leeuw I, Hermansen K, Karamanos B, Karlström B, Katsilambros N, The Diabetes and Nutrition Study Group (DNSG), The European Association for the Study of Diabetes (EASD) et al (2004) Evidence based nutritional approaches to the treatment and prevention of diabetes mellitus. Nutr Metab Cardiovasc Dis 14:373–394CrossRefGoogle Scholar
- 12.National Nutrition Committee CDA (1999) Guidelines for the nutritional management of diabetes mellitus in the new millennium: a position statement by the Canadian Diabetes Association. Can J Diabetes Care 23:56–69Google Scholar
- 13.Diabetes and Nutrition Study Group, of the European Association for the Study of Diabetes (1995) Recommendations for the nutritional management of patients with diabetes mellitus. Diabetes Nutr Metab 8:186–189Google Scholar
- 15.Krauss RM, Eckel RH, Howard BV, Appel LJ, Daniels SR, Deckelbaum RJ, Erdman JW, Kris-Etherton P, Goldberg IJ, Kotchen TA et al (2000) AHA Guidelines Revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation 102:2284–2299CrossRefGoogle Scholar
- 16.Expert Panel on Detection, Valuation, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486–2497CrossRefGoogle Scholar
- 18.Vaccaro O, Masulli M, Bonora E, Del Prato S, Giorda CB, Maggioni AP et al (2012) Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: impact on cardiovascular events. A randomized controlled trial. Nutr Metab Cardiovasc Dis 22(11):997–1006CrossRefGoogle Scholar
- 20.Pala V, Sieri S, Palli D, Salvini S, Berrino F, Bellegotti M et al (2003) Diet in the Italian EPIC cohorts: presentation of data and methodological issues. Tumori 89(6):594–607Google Scholar
- 22.Salvini S, Parpinel M, Gnagnarella P, Maisonneuve P, Turrini A (eds) (1998) Banca dati di composizione degli alimenti per studi epidemiologici in Italia. Istituto Europeo di Oncologia, MilanGoogle Scholar
- 23.Carnovale E, Marletta L (eds) (2000) Tabella di composizione degli alimenti. INRANGoogle Scholar
- 24.Foster-Powell K, Holt SHA, Brand-Miller JC (2002) International table of glycemic index and glycemic load values: 2002. Am J Clin Nutr 76:5–56Google Scholar
- 25.AMD & SID (2014) Standard Italiani per la cura del diabete mellito. Ed. InfomedicaGoogle Scholar